DMIIR
Drugs Made In America Acquisition II Corp.
Set alert
0.05 USD 0.00 -0.76%
0.0522 Day range 0.053
0.0522 52-week range 0.0522
- YTD
- 0.00%
- 1 year
- 0.00%
- Open
- 0.053
- Prev close
- 0.0526
- Mkt cap
- 3.35M
- Vol
- 2.49K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0522
- High
- 0.053
Financial health
FMP rating
A-4 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 4
- Debt / Equity 5
- P/E 5
- P/B 5
Valuation
P/E 2.2×
FY 2024 5y median -32.3× FY 2025
P/S 0.0×
FY 2024 5y median 0.0× FY 2025
P/B 0.0×
FY 2024 5y median -43.7× FY 2025
P/FCF -8.9×
FY 2024 5y median -30.7× FY 2025
EV/EBITDA -6.9×
FY 2024 5y median -37.8× FY 2025
EV/Sales 0.0×
FY 2024 5y median 0.0× FY 2025
FCF Yield -11.3%
FY 2024 5y median -6.6% FY 2025
Profitability
Gross Margin 0.0%
FY 2024 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2024 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2024 5y median 0.0% FY 2025
ROE 0.9%
FY 2024 5y median 65.4% FY 2025
ROIC -0.3%
FY 2024 5y median -57.0% FY 2025
ROA 0.8%
FY 2024 5y median -54.5% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2024 FY 2025
Operating Income -757.2%
FY 2024 FY 2025
EPS (diluted) 2808.3%
FY 2024 FY 2025
Free Cash Flow -424.1%
FY 2024 FY 2025
Financial Health
Current Ratio 0.1×
FY 2024 5y median 0.2× FY 2025
Quick Ratio 0.1×
FY 2024 5y median 0.2× FY 2025
Debt / Equity 0.0×
FY 2024 5y median -1.1× FY 2025
Net Debt / EBITDA 0.0×
FY 2024 5y median -0.8× FY 2025
Interest Coverage 0.0×
FY 2024 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2024 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2024 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31